A Combination of Inflammatory and Hematological Markers is Strongly Associated with the Risk of Death in Both Mild and Severe Initial Disease in Unvaccinated Individuals with COVID-19 Infection

BACKGROUND: Inflammatory and hematological markers are used extensively for early prognostication and monitoring in COVID-19. We aimed to determine whether routinely prescribed laboratory markers can predict adverse outcome at presentation in COVID-19. METHODS: This retrospective observational study...

Descripción completa

Detalles Bibliográficos
Autores principales: Chopra, Parul, Sehgal, Tushar, Yadav, Ranjan, Meena, Suneeta, Maitra, Souvik, Soni, Kapil Dev, Subramanian, Arulselvi, Prakash, Shyam, Mathur, Purva, Mittan, Sandeep, Tavolacci, Sooyun, Kaushik, Ajeet, Gulia, Kiran, Mostafavi, Ebrahim, Gupta, Abhishek, Trikha, Anjan, Gupta, Ritu, Chosdol, Kunzang, Mohan, Anant, Mani, Kalaivani, Sinha, Subrata, Datta, Sudip Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Communications and Publications Division (CPD) of the IFCC 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131235/
https://www.ncbi.nlm.nih.gov/pubmed/37124653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131235/
https://www.ncbi.nlm.nih.gov/pubmed/37124653

Ejemplares similares